A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome.

• Main Authors: Koichiro Suemori (Author), Masayuki Saijo (Author), Atsushi Yamanaka (Author), Daisuke Himeji (Author), Masafumi Kawamura (Author), Takashi Haku (Author), Michihiro Hidaka (Author), Chinatsu Kamikokuryo (Author), Yasuyuki Kakihana (Author), Taichi Azuma (Author), Katsuto Takenaka (Author), Toru Takahashi (Author), Akitsugu Furumoto (Author), Toshiyuki Ishimaru (Author), Masayuki Ishida (Author), Masahiko Kaneko (Author), Norimitsu Kadowaki (Author), Kenichi Ikeda (Author), Shigetoshi Sakabe (Author), Tomohiro Taniguchi (Author), Hiroki Ohge (Author), Takeshi Kurosu (Author), Tomoki Yoshikawa (Author), Masayuki Shimojima (Author), Masaki Yasukawa (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Severe fever with thrombocytopenia syndrome (SFTS) is a bunyavirus infection with high mortality. Favipiravir has shown effectiveness in preventing and treating SFTS virus (SFTSV) infection in animal models. A multicenter non-randomized, uncontrolled single arm trial was conducted to collect data on...